Bdsure 22.5mg Injection

About

Bdsure 22.5mg Injection is an extended-release intramuscular formulation of an atypical antipsychotic, designed for the long-term management of certain psychiatric conditions. It works by modulating the activity of dopamine and serotonin neurotransmitters in the brain, helping to stabilize mood, reduce psychotic symptoms, and prevent relapse. The sustained-release mechanism ensures a consistent therapeutic drug level over an extended period, typically several weeks, which significantly improves medication adherence and reduces the burden of daily oral dosing. This injection is administered by a healthcare professional and is a vital option for patients requiring continuous and reliable antipsychotic treatment to maintain mental stability and improve quality of life.

Uses

• Schizophrenia (maintenance treatment)
• Bipolar I Disorder (maintenance treatment)
• Major Depressive Disorder (adjunctive therapy)
• Psychotic disorders (long-term management)

Directions For Use

Administered intramuscularly by a healthcare professional, typically once every 4-6 weeks. Do not self-inject.

Benefits

• Improves medication adherence significantly
• Provides consistent drug levels over time
• Reduces the risk of symptom relapse
• Offers convenient, less frequent dosing
• Helps stabilize mood and reduce psychosis
• Supports long-term disease management

Side Effects

• Injection site reactions (pain, redness)
• Weight gain
• Akathisia (restlessness)
• Somnolence (drowsiness)
• Dizziness and lightheadedness
• Headache
• Nausea and vomiting
• Constipation
• Tremor
• Extrapyramidal symptoms (e.g., dystonia)
• Orthostatic hypotension
• Metabolic changes (e.g., blood sugar)

Safety Measures

• Alcohol - Avoid alcohol as it can exacerbate CNS depressant effects and increase drowsiness.
• Pregnancy - Consult doctor. Use only if potential benefit outweighs risk; monitor neonate for withdrawal symptoms.
• Breastfeeding - Consult doctor. Excreted in breast milk; potential for adverse effects in the infant.
• Liver - Use with caution; dose adjustment may be necessary in patients with hepatic impairment.
• Kidney - Use with caution; dose adjustment may be necessary in patients with renal impairment.
• Lung - No specific contraindication, but monitor for respiratory depression if co-administered with other CNS depressants.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.